Description
Springer Controversies in the Management of Lymphomas Including Hodgkins disease 1st Editon 2011 Softbound by John M. Bennett
Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, geni tourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more. 1. The Lukes-Butler classification of Hodgkin’s disease revisited.- 2. Pitfalls in the diagnosis and classification of Hodgkin’s disease: Surgical pathology and classification for the 1980’s — Is the Lukes-Butler classification still relevant?.- 3. The Reed-Sternberg cell: Biological and clinical significance.- 4. Upon the enigma of Hodgkin’s disease and the Reed-Sternberg cell.- 5. Selection of an imaging modality for staging abdominal involvement in the malignant lymphomas — Lymphography or computed tomography?.- 6. The definitive management of limited and intermediate stages of Hodgkin’s disease with radiation therapy alone.- 7. The role of combination chemotherapy alone or as an adjuvant to radiation therapy in limited stages of Hodgkin’s disease.- 8. Chemotherapy for stage IIIA Hodgkin’s disease: The proper role.- 9. The Rappaport classification of the non-Hodgkin’s lymphomas: Is it pertinent for the 1980’s?.- 10. Nodular mixed cell lymphoma: Is there a potential for a prolonged disease free survival and cure?.- 11. Nodular mixed lymphoma: Failure to demonstrate prolonged disease free survival and cure.- 12. The role of treatment deferral in the management of patients with advanced, indolent non-Hodgkin’s lymphomas.- 13. Early intervention with combined modality therapy for ‘favorable’ non-Hodgkin’s lymphomas of advanced stage.